A SpringMed Kiadó könyveit 20% kedvezménnyel megvásárolhatja a kiadónál!
Vagy megrendelheti honlapunkon, telefonon, faxon, illetve levélben!
Várjuk kérdéseit, észrevételeit!

Könyvajánlók

Amit a tüdőrákról tudni kell

Magas vérnyomás

Vegetáriánus konyha - Frisset, ízleteset kreatívan

Allergia - öröklődés - megelőzés

Szerzők:

• Briggs, Andrew H.

Kiadás:

Kiadó: Office of Health Economics
ISBN 1899040722
2003

Könyvajánlók ebben a kategóriában

Kérjük válasszon tartalmat:

Fülszöveg

Health economic evaluation has come of age. There are few industrialised countries that do not now recognise the importance for decision making of evidence on the cost effectiveness of interventions. Cost effectiveness evidence is not a formal regulatory requirement in the licensing of new medications. But it is clear that bodies such as the National Institute for Clinical Excellence (NICE) in the UK, the Canadian Coordinating Office for Health Technology Assessment (CCHOTA) and the Pharmaceutical Benefits Advisory Committee (PBAC) in Australia are part of a general trend towards the direct use of cost effectiveness information to decide on health care interventions for routine clinical practice....
It is an exciting time for health economic evaluation. The methods for undertaking cost effectiveness analysis alongside clinical trials are still evolving. It is clear that there is room for much further refinement and development of the methods described in this book. It is hoped that this introduction to the use of statistical methods for cost effectiveness analysis will serve not only as a guide to the practising researcher on the application of appropriate methods, but also as an inspiration to develop the methods still further.